Trial intelligence / Profile preview

L-carnitine for Dyslipidemia in Hemodialysis

NCT01278693Phase 2Completed

Start
Aug 2009
Primary completion
Sep 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of levocarnitine in dyslipidemia, anemia. Started Aug 2009; status: completed.

02

Drugs

levocarnitine
03

Conditions

dyslipidemiaanemia

Beyond the preview

Go deeper on NCT01278693.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01278693.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call